Safe Implant Technology ApS: Financial statements 2021
CVR: 38969153
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Safe Implant Technology ApS (CVR 38969153) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -6,796 and a net result of DKK -6,966 compared with DKK -3,125 the year before. Equity in the 2021 report amounted to DKK 33,659. The solvency ratio was 4.7%.
- Gross Profit
- DKK -6,796
- Profit/Loss
- DKK -6,966
- Equity
- DKK 33,659
- Total Assets
- DKK 710,609
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -7 t. | -7 t. | 34 t. | 0 |
| 2020 | - | -3 t. | -3 t. | 41 t. | 0 |
| 2019 | - | -3 t. | -3 t. | 44 t. | 0 |
Official annual report
Find more companies like Safe Implant Technology ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Safe Implant Technology ApS has published its annual report for 2020. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
As of June 30, 2021, MBA STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of Safe Implant Technology ApS.
About Safe Implant Technology ApS
Safe Implant Technology ApS is a Danish company of the type Anpartsselskab based in Fårevejle, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov. The board consists of Søren Luplau-Pagh (chair), Gorm Danscher, Henrik Nakskov and Lone Damgaard Horup. The company is owned by BERLOCK ApS and Devopharma ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 756,423 and a net result of DKK -53,855 compared with DKK -724,511 the year before. Equity in the 2025 report amounted to DKK -946,258.